Valuation: STCube, Inc.

Market Cap 441B 304M 267M 249M 229M 428M 29.11B 439M 2.96B 1.16B 14.4B 1.14B 1.12B 49.79B P/E 2024
-19.4x
P/E 2025 -25.6x
Enterprise Value 383B 264M 232M 217M 199M 372M 25.31B 382M 2.57B 1.01B 12.53B 992M 971M 43.3B EV / Sales 2024
44.3x
EV / Sales 2025 71.5x
Free-Float
92.57%
Yield 2024 *
-
Yield 2025 -
24-10-23 STCube, Inc. announced that it has received KRW 13.00000464 billion in funding CI
24-08-25 STCube, Inc. announced that it expects to receive KRW 13.00000464 billion in funding CI
24-03-27 STCube, Inc.(KOSDAQ:A052020) dropped from S&P Global BMI Index CI
23-09-06 Global markets live: Apple, Alphabet, Roku, Amazon, General Mills... Zonebourse
23-03-21 STCube, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
22-03-07 STCube to Raise $36 Million via Stock Sale; Shares Surge 10% MT
20-12-27 STCube, Inc. announced that it has received KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
20-12-17 STCube, Inc. announced that it expects to receive KRW 9.9999921 billion in funding from Newgreen Co. Ltd. and another investor CI
20-07-11 Samsung Biologics Signs Additional Development and Manufacturing Agreement with STCube CI
20-03-02 Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug CI
18-05-24 STCube, Inc. announced that it has received KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm CI
18-04-24 STCube, Inc. announced that it expects to receive KRW 41.999908468 billion in funding from Mirae Asset Daewoo Co., Ltd., Investment Arm, Shinhan Investment Corp., Samsung Securities Co.,Ltd., Hana Bank, Investment Arm and other investors CI
16-09-19 STCube, Inc.(KOSDAQ:A052020) added to S&P Global BMI Index CI
1 day-7.29%
1 week-10.24%
Current month-24.88%
1 month-28.68%
3 months-70.63%
6 months-22.65%
Current year-20.85%
1 week 6,010
Extreme 6010
7,810
1 month 6,010
Extreme 6010
8,810
Current year 6,010
Extreme 6010
22,500
1 year 6,010
Extreme 6010
22,500
3 years 3,940
Extreme 3940
22,500
5 years 3,940
Extreme 3940
28,500
10 years 3,940
Extreme 3940
28,600
Manager TitleAgeSince
Chief Executive Officer 61 2013-03-28
Director of Finance/CFO 54 -
Chief Tech/Sci/R&D Officer 62 2014-02-28
Director TitleAgeSince
Director/Board Member 61 2013-02-28
Director/Board Member 54 2013-02-28
Director/Board Member 62 2014-02-28
Date Insider Type Main position Quantity % Market Cap.
12/3/24 Buy

Chief Financial Officer

47,582 0.0730%
12/3/24
Bio Medical Holdings Corp.
BuyCompany 449,447 0.6892%
12/3/24 Buy

Chief Executive Officer

18,346 0.0281%
Change 5-day change 1-year change 3-year change Capi.($)
-7.29%-10.24%-7.15%-52.14% 327M
+2.33%+9.51%+44.93%+24.11% 105B
-9.06%-18.88%+98.88%+281.84% 41.53B
-4.59%-14.14%+157.69%+574.86% 40.69B
+5.46%-7.20%+59.97%+165.91% 33.95B
-2.82%-2.94%+14.28%+65.27% 30.12B
+0.69%-2.21%+120.85%+90.11% 28.89B
+12.16%+20.05%-13.22%-7.35% 23.68B
-3.40%-6.88%+5.70%+51.69% 17.74B
+1.66%+0.82%+33.37%+97.58% 13.59B
Average -0.55%-5.07%+51.53%+129.19% 33.56B
Weighted average by Cap. +0.01%-4.77%+63.89%+148.63%

Financials

2024 2025
Net sales 11.3B 7.79M 6.84M 6.39M 5.86M 10.97M 746M 11.24M 75.73M 29.62M 369M 29.23M 28.6M 1.28B 6.98B 4.81M 4.23M 3.95M 3.62M 6.78M 461M 6.95M 46.82M 18.31M 228M 18.07M 17.68M 789M
Net income -21.44B -14.77M -12.98M -12.12M -11.12M -20.82M -1.42B -21.33M -144M -56.2M -700M -55.47M -54.27M -2.42B -21.8B -15.02M -13.2M -12.32M -11.31M -21.17M -1.44B -21.69M -146M -57.15M -712M -56.41M -55.19M -2.46B
Net Debt -79.55B -54.83M -48.18M -44.97M -41.27M -77.25M -5.25B -79.16M -533M -209M -2.6B -206M -201M -8.98B -57.42B -39.57M -34.77M -32.46M -29.79M -55.76M -3.79B -57.14M -385M -151M -1.88B -149M -145M -6.48B
Logo STCube, Inc.
STCube Inc is a Korea-based company mainly engaged in the distribution of lens modules and related components. The Company operates its business through two segments. The Distribution segment is engaged in the industrial lens modules and related parts distribution, basic skin care products distribution and Cynthia basic skin care products manufacture and distribution business. The Biotechnology segment is engaged in the research, development and licensing of immunomodulatory anticancer drug therapeutic candidates.
Employees
13
Date Price Change Volume
26-07-29 ₩6,490.00 -7.29% 402,955
26-07-28 ₩7,000.00 -7.77% 277,395
26-07-27 ₩7,590.00 +2.15% 174,319
26-07-24 ₩7,430.00 0.00% 145,474
26-07-23 ₩7,430.00 +2.77% 152,766
  1. Stock Market
  2. Stocks
  3. A052020 Stock